The relation between memory and exam performance - modulation with Methylphenidate
- Conditions
- geen aandoeningnot applicable
- Registration Number
- NL-OMON52652
- Lead Sponsor
- niversiteit Maastricht
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 80
• In the opinion of the investigator, the participant is capable of
understanding and complying with protocol requirements.
• The participant has a body mass index of 18.5-30 kg/m2, inclusive, at the
medical screening.
• The participant is aged 18 to 35 years, inclusive, at the time of informed
consent.
• The volunteer is healthy, i.e. absence of all exclusion criteria and had
normal or corrected to normal static binocular acuity with or without
correction.
• The participant signs and dates a written informed consent form before the
start of the experiment.
• The participant has sufficient English language skills to read and understand
all instructions and perform the tasks in this study
• The volunteer has an uncontrolled, clinically significant neurologic,
cardiovascular, pulmonary, hepatic, renal, metabolic, gastrointestinal, or
endocrine disease or other ab-normality, which may impact the ability of the
subject to participate or potentially confound the study results.
• The volunteer has existing major psychiatric symptoms.
• The participant has known hypersensitivity to any component of the
formulation or methylphenidate or related compounds.
• The participant has a history of drug abuse (defined as any illicit drug use)
or a history of alcohol abuse within 1 year prior to the first visit or is
unwilling to agree to abstain from alcohol from 24 hours prior to each test day
and/or drugs throughout the study.
• The participant has been diagnosed with ADHD.
• The participant has any sensory or motor deficits, which could reasonably be
expected to affect test performance.
• Other exclusion criteria are excessive drinking (>20 glasses of
alcohol-containing beverages a week), pregnancy or lactation, use of medication
other than oral contraceptives, use of recreational drugs from 2 weeks before
until the end of the experiment, any condition in which gastrointestinal
motility might carry any risk.
• The participant has dyslexia.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method